Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,597.61
(
-0.03%
)
US TECH 100
29,745.80
(
0.12%
)
Dow Jones
50,950.20
(
-0.25%
)
Brent Oil
94.42
(
-1.62%
)
Bitcoin
67,876.00
(
-4.89%
)
News Focus
News Focus
Post# of 2446
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

aslan2772

Send PM Follow Ignore
Followers 2
Posts 660
Boards Moderated 0
Alias Born 10/30/2004

aslan2772

Re: DewDiligence post# 1190

Monday, 04/23/2007 6:18:21 PM

Monday, April 23, 2007 6:18:21 PM

Post# of 2446
"The terminology “f(Ab)” looks like a thinly-veiled reference to Lucentis/Avastin."

I agree. In the context of back of the eye diseases, what other product could it be applicable to? The big question is whether Genentech is funding or has agreed to fund any of the preclinical research. At the very least, Surmodics is making quite a display of courship to Genentech.

I would not be surprised of one of these projects was code named "Peacock" ;)

The obstacle to discovery is the illusion of knowledge.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SRDX News
More SRDX News